Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eurofins MWG Operon LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10887
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurofins MWG Operon LLC (Eurofins) is a DNA sequencing service provider. The company offers DNA sequencing services, DNA synthesis products, and bioinformatic services. Its product categories comprise DNA and RNA synthesis, DNA sequencing, GENE synthesis and next gen seq. Eurofins provides next gen DNA technology express oligos, extremer oligos, custom DNA oligos, custom RNA/chimeric oligos, NGS application oligos, QPCR / MGB probes, crisprs products, simax sirna, purification and yields and modifications. The company also offers sequencing dashboard, overnight sequencing, simpleseq kits, flexreads, tube sequencing, plate sequencing, fragment analysis, plasmid verification, clinical and GLP services and standard primers. The company has its presence in the US, India, Europe and Japan. Eurofins is headquartered in Louisville, Kentucky, the US.

Eurofins MWG Operon LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Rubicon Genomics Enters into Distribution Agreeement with Eurofins MWG Operon 11
Eurofins MWG Operon And Floragenex Enter Into Co-Marketing Agreement For RAD Sequencing Services 12
Acquisition 13
Eurofins MWG Operon Acquires Entelechon, Gene Synthesis Provider 13
Eurofins MWG Operon LLC – Key Competitors 14
Eurofins MWG Operon LLC – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Mar 14, 2017: Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service 16
Jan 16, 2017: Eurofins Genomics Expands Express Oligo Service 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Key Facts 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rubicon Genomics Enters into Distribution Agreeement with Eurofins MWG Operon 11
Eurofins MWG Operon And Floragenex Enter Into Co-Marketing Agreement For RAD Sequencing Services 12
Eurofins MWG Operon Acquires Entelechon, Gene Synthesis Provider 13
Eurofins MWG Operon LLC, Key Competitors 14
Eurofins MWG Operon LLC, Other Locations 15
Eurofins MWG Operon LLC, Subsidiaries 15

List of Figures
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • mBank Private Banking:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "mBank Private Banking" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Nidec Corporation:企業の戦略・SWOT・財務分析
    SummaryNidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • EcoSecurities Group Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EcoSecurities Group Plc Mergers …
  • Mintails Limited (MLI):企業の財務及び戦略的SWOT分析
    Summary Mintails Limited (Mintails) is a mineral exploration company that acquires, develops and explores gold properties in the Witwatersrand, South Africa. The company explores for gold and other metals. It has operations in West Rand of the Witwatersrand Basin, near Johannesburg, South Africa. Mi …
  • Pedernales Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Pedernales Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Genzyme Corporation:企業の戦略・SWOT・財務分析
    SummaryGenzyme Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • TelaDoc Inc (TDOC):企業財務及び戦略的SWOT分析
    Summary TelaDoc Inc (Teladoc) is a healthcare service provider that provides telehealth services to the healthcare market. The company offers short term prescription for Amoxicillin, Azithromycin, Bactrim DS, Augmentin, Cipro, Tessalon Perles, Flonase Nasal Spray, Pyridium, Prednisone and Diflucan. …
  • Metro Pacific Investments Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Metro Pacific Investments Corpo …
  • Swedish Orphan Biovitrum AB:企業のM&A・提携・投資分析
    Swedish Orphan Biovitrum AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swedish Orphan Biovitrum AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Vozrozhdenie Bank (VZRZ):企業の財務・戦略的SWOT分析
    Summary Vozrozhdenie Bank (VB) is a banking service provider that provides corporate business, retail business, bank cards transactions and financial market operations. The company provides personal banking and business services. It products include debit and credit cards, accounts, and others. VB o …
  • Automatic Data Processing, Inc.:企業の戦略・SWOT・財務分析
    SummaryAutomatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Tata Teleservices (Maharashtra) Limited (TTML):企業概要、財務及び戦略的SWOT分析
    Summary Tata Teleservices (Maharashtra) Limited (TTML) is a provider of telecommunication services to its customer across Maharashtra, India. The company operates as a subsidiary of Tata Sons Limited, a part of TATA Group of companies. It offers telecommunication services such as mobile, fixed wirel …
  • Orthofix International N.V. (OFIX)-医療機器分野:企業M&A・提携分析
    Summary Orthofix International N.V. (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation prod …
  • Raybiotech, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Raybiotech, Inc. Mergers and Ac …
  • Toa Corp (1885):企業の財務・戦略的SWOT分析
    Toa Corp (1885) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Harvest Natural Resources, Inc. (HNR):企業財務及び戦略的SWOT分析
    Summary Harvest Natural Resources, Inc. (HNR) is an oil and gas company that acquires, explores, develops, and produces oil and natural gas fields. The company provides exploration for and the acquisition and development of oil and gas fields in known hydrocarbon basins. Its assets comprise Bombal f …
  • LDR Holding Corporation (LDRH):企業のM&A・提携動向(医療機器分野)
    Summary LDR Holding Corporation (LDR) is a medical device company that designs and commercializes surgical technologies for the treatment of spine disorders. The company develops its products based on its VerteBRIDGE fusion and Mobi non-fusion platforms, which have application in cervical and lumbar …
  • Triangle Energy (Global) Limited (TEG):企業概要、財務及び戦略的SWOT分析
    Summary Triangle Energy (Global) Limited (Triangle Energy) is an oil and gas exploration company. The company carries out exploration and production of oil and gas reserves in Indonesia. Its assets include Pase Field, and Reid’s Dome. Triangle Energy holds working interest and operates the Productio …
  • Eurofarma Laboratorios SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products such as aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoruracila …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆